SARASOTA, Fla. and MIAMI, Jan. 13, 2025 (GLOBE NEWSWIRE) -- NAYA Biosciences (“NAYA”) (NASDAQ: NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients...
• PD-1 x VEGF antibodies show potential to surpass checkpoint inhibitors as standard-of-care in multiple oncology indications • NAYA aiming to initiate clinical trials in early 2026 SARASOTA...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.3342 | -40.0623351714 | 0.8342 | 0.85 | 0.4111 | 306789 | 0.49877639 | CS |
4 | -0.255 | -33.7748344371 | 0.755 | 1.04 | 0.4111 | 342294 | 0.82515022 | CS |
12 | -0.3843 | -43.4581024539 | 0.8843 | 1.04 | 0.4111 | 158610 | 0.83031139 | CS |
26 | -0.51 | -50.495049505 | 1.01 | 1.18 | 0.4111 | 258444 | 0.89915953 | CS |
52 | -0.51 | -50.495049505 | 1.01 | 1.18 | 0.4111 | 258444 | 0.89915953 | CS |
156 | -0.51 | -50.495049505 | 1.01 | 1.18 | 0.4111 | 258444 | 0.89915953 | CS |
260 | -0.51 | -50.495049505 | 1.01 | 1.18 | 0.4111 | 258444 | 0.89915953 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관